Genomically Recoded Cells for Stable Toxic Protein Production

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for maintaining and manipulating DNA sequences in microbial host cells, such as E. coli, face challenges due to toxicity and metabolic burden from DNA sequences, particularly eukaryotic or viral sequences, which are unstable and difficult to clone due to cryptic bacterial promoters, leading to expression of toxic proteins or peptides.

Innovation Solution

Genomically recoded cells or organisms are created by altering native genes to eliminate tRNA cognates for specific codons, rendering them unassigned, and introducing foreign nucleic acid sequences containing these codons, which prevents initial translation and allows for controlled expression through exogenous tRNA supply, enabling stable propagation and high-yield protein production.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If foreign nucleic acid sequences (eukaryotic or viral) are introduced into microbial host cells, then the ability to produce diverse proteins is improved, but stability and cloning ease deteriorate due to cryptic bacterial promoters causing toxic protein expression

Engineering Contradiction:
Improveability to produce diverse proteinsVSAvoidstability of foreign nucleic acid sequences
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The patent extracts and removes cryptic bacterial promoters from foreign nucleic acid sequences through site-directed mutagenesis or promoterless vector design, eliminating the source of toxic protein expression while preserving the coding sequences for desired protein production

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent introduces intermediary regulatory elements such as inducible promoters (e.g., T7 promoter with lac operator) that act as mediators between the foreign nucleic acid sequences and the host cell's transcriptional machinery, allowing controlled expression only when needed

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of manufacture

If cryptic bacterial promoters in foreign sequences are left intact, then cloning simplicity is improved, but metabolic burden increases due to expression of toxic proteins or peptides

Engineering Contradiction:
Improvecloning simplicityVSAvoidtoxicity from expressed proteins
Core Design Contradiction:
Ease of manufactureVSObject-generated harmful factors

Solution Approach 1:

The patent converts the potentially harmful effect of cryptic promoters into a beneficial selection mechanism by designing systems where promoter activity serves as a marker for successful cloning events, allowing easy identification of correctly transformed cells while controlling toxic expression

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

3Productivity

If DNA sequences are maintained in microbial host cells, then productivity for protein production is improved, but metabolic burden increases leading to reduced cell growth and stability

Engineering Contradiction:
Improveprotein production yieldVSAvoidmetabolic burden on host cells
Core Design Contradiction:
ProductivityVSUse of energy by moving object

Solution Approach 1:

The patent implements periodic or inducible expression systems where foreign genes are expressed only at specific times or under specific conditions (e.g., addition of IPTG, temperature shift), allowing cells to grow normally during propagation and produce proteins only when induced, thereby reducing overall metabolic burden

Inventive Principle:
Principle #19Periodic action

Data Source

PatentUS20240002865A1Methods for Making and Using Genomically Recoded Cells
Publication Date: 2024.01.04 PRESIDENT & FELLOWS OF HARVARD COLLEGE
  • US20240002865A1 patent drawing
  • US20240002865A1 patent drawing
  • US20240002865A1 patent drawing

AI summary

Methods making and using genomically recoded cells or organisms are provided including genomically recoded cells or organisms that lack the ability to translate a foreign nucleic acid sequence into a polypeptide that may be toxic to the genomically recoded cell or organism.